Issue 5/2009
Content (13 Articles)
Guanfacine extended release in the treatment of attention-deficit/hyperactivity disorder
Anthony L. Rostain
Lisdexamfetamine in the treatment of attention-deficit/hyperactivity disorder in adults
Anthony L. Rostain
Substance abuse in the United States: Findings from recent epidemiologic studies
Jeffrey D. Schulden, Yonette F. Thomas, Wilson M. Compton
Treatment of opioid-dependent adolescents and young adults with buprenorphine
Geetha A. Subramaniam, Marc J. Fishman, George Woody
Adaptive interventions may optimize outcomes in drug courts: A pilot study
Douglas B. Marlowe, David S. Festinger, Patricia L. Arabia, Karen L. Dugosh, Kathleen M. Benasutti, Jason R. Croft
Gene-environment interactions in attention-deficit/hyperactivity disorder
Courtney A. Ficks, Irwin D. Waldman
New insights into attention-deficit/hyperactivity disorder using structural neuroimaging
Philip Shaw, Cara Rabin
DSM-V and the future diagnosis of attention-deficit/hyperactivity disorder
James M. Swanson, Timothy Wigal, Kimberley Lakes
School-based interventions for students with attention-deficit/hyperactivity disorder
Thomas J. Power, Katy E. Tresco, Michael C. Cassano
College students with attention-deficit/hyperactivity disorder
Lorraine E. Wolf, Philip Simkowitz, Heather Carlson